Article Sidebar

PDF
Date Published: 18/10/2021
Abstract Views: 530
Views PDF: 397
DOI: https://doi.org/10.51298/vmj.v506i1.1195
Issue
Vol. 506 No. 1 (2021)
Section
Các bài báo
How to Cite
Anh Vinh, N. . (2021). CLINICAL AND LABORATORY INVESTIGATIONS FEATURES OF DILATED CARDIOMYOPATHY IN CHILDREN AT VIETNAM NATIONAL CHILDREN’S HOSPITAL. Vietnam Medical Journal, 506(1). https://doi.org/10.51298/vmj.v506i1.1195

CLINICAL AND LABORATORY INVESTIGATIONS FEATURES OF DILATED CARDIOMYOPATHY IN CHILDREN AT VIETNAM NATIONAL CHILDREN’S HOSPITAL

Ngô Anh Vinh1,
1 Vietnam National Children's Hospital

Main Article Content

Abstract

Objective: To describe common clinical signs and laboratory investigations of dilated cardiomyopathy in children. Subjects and methods: A cross-sectional descriptive study on 34 patients diagnosed and treated with dilated cardiomyopathy at Vietnam National Children's Hospital. Results: Heart failure (100%), dyspnea (76,5%), hepatomegaly (73,53%), tachycardia (61,76%), enlarged heart shadow on chest X-ray (100%), systolic dysfunction (94,1%), ventricular thickening on electrocardiogram (35,3%). Conclusion: Heart failure, enlarged heart on chest X-ray, and systolic dysfunction are common in dilated cardiomyopathy.

Article Details

Keywords

Dilated cardiomyopathy, clinical, laboratory investigations, children

References

1. Alexander P.M, Daubeney P.E, Nugent A.W, et al (2013). Long-term outcomes of dilated cardiomyopathy diagnosed during childhood: results from a national population-based study of childhood cardiomyopathy. Circulation, 128(18), 2039-2046.
2. Molina K.M, Shrader P, Colan S. D, et al (2013). Predictors of disease progression in pediatric dilated cardiomyopathy. Circ Heart Fail,6(6), 1214-1222.
3. Towbin J.A, Lowe A.M, Colan S.D, et al (2006). Incidence, causes, and outcomes of dilated cardiomyopathy in children. JAMA, 296(15), 1867-1876.
4. Đặng Phương Thuý (2017). Giá trịcủa nồng độ NT-proBNP trong theo dõi bệnh cơ tim giãn ởtrẻem. Luận văn tốt nghiệp bác sĩ nội trú, Trường Đại học Y Hà Nội.
5. Randy Wexler, Terry Elton, Adam Pleister, et al (2009). Cardiomyopathy: An Overview. Am Fam Physician,79(9): 778–784.
6. Susanna B.S, Rizopoulos D, Marchie S.G, et al (2016). Usefulness of Serial N-terminal Pro-B-type Natriuretic Peptide Measurements to Predict Cardiac Death in Acute and Chronic Dilated Cardiomyopathy in Children. Am J Cardiol, 118(11), 1723-1729.
7. Alvarez J.A, Orav E.J, Wilkinson J.D, et al (2011). Competing Risks for Death and Cardiac Transplantation in Children with Dilated Cardiomyopathy: Results from the Pediatric Cardiomyopathy Registry. Circulation, 124(7), 814-823.